AERASE INC has a total of 28 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are GENKYOTEX, ELICIO THERAPEUTICS INC and HEINO PEKKA UNTAMO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Canada | 3 | |
#4 | Australia | 2 | |
#5 | Republic of Korea | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Brazil | 1 | |
#8 | China | 1 | |
#9 | United Kingdom | 1 | |
#10 | Hong Kong | 1 | |
#11 | Israel | 1 | |
#12 | Mexico | 1 | |
#13 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Enzymes | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Rowlinson Scott W | 14 |
#2 | Georgiou George | 9 |
#3 | Stone Everett | 9 |
#4 | Quinn Anthony G | 8 |
#5 | Lowe David | 6 |
#6 | Alters Susan | 6 |
#7 | Agnello Giulia | 6 |
#8 | Giulia Agnello | 3 |
#9 | David Lowe | 3 |
#10 | Scott W Rowlinson | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020081994A1 | Arginine depletion therapy for treatment of gamt deficiency | |
CN111787941A | Methods and compositions for treating arginase 1deficiency | |
BR112019002458A2 | compositions and methods for treating arginine-depleted cancer and immuno-oncologic agents | |
CA3073583A1 | Compositions and methods for treating cancer with arginine depletion and immuno oncology agents |